Bioverativ Therapeutics, Inc. — H1B Data for FY2023
FY2023 H1B Overview for Bioverativ Therapeutics, Inc.
In fiscal year 2023, Bioverativ Therapeutics, Inc. filed 1 H1B labor condition applications with the U.S. Department of Labor. Of these, 1 were certified and 0 were denied. The average salary offered on these applications was $141,149.
The applications covered a total of 1 worker positions, as a single LCA can cover multiple workers in the same role and location.
Bioverativ Therapeutics, Inc. also filed 2 PERM (green card) applications in FY2023, with 1 certified, indicating ongoing commitment to long-term sponsorship for foreign workers.
View Bioverativ Therapeutics, Inc.'s complete sponsorship history on the full employer profile, including all years, job titles, and salary trends. Learn more about the H1B visa program in our comprehensive H1B visa guide.
FY2023 H1B Filings by Bioverativ Therapeutics, Inc.
Individual labor condition applications filed by Bioverativ Therapeutics, Inc. in fiscal year 2023. There are 1 filings total.
| Case # | Status | Job Title | Salary | Location | Date |
|---|---|---|---|---|---|
| I-200-23191-177763 | Certified | Clinical Supply Project Operational Leader | $141,149 – $154,500 | Waltham, MA | 2023-07-17 |
Bioverativ Therapeutics, Inc. H1B History by Year
Browse Bioverativ Therapeutics, Inc.'s H1B filing data for other fiscal years.